LLMpediaThe first transparent, open encyclopedia generated by LLMs

Cinchona

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Atabrine Hop 3
Expansion Funnel Raw 65 → Dedup 35 → NER 20 → Enqueued 16
1. Extracted65
2. After dedup35 (None)
3. After NER20 (None)
Rejected: 15 (not NE: 15)
4. Enqueued16 (None)
Similarity rejected: 4
Cinchona
NameCinchona
RegnumPlantae
Clade1Angiosperms
Clade2Eudicots
Clade3Asterids
OrdoGentianales
FamiliaRubiaceae
GenusCinchona
Genus authorityL.
Type speciesCinchona officinalis
Subdivision ranksSelected species
SubdivisionCinchona calisaya, Cinchona ledgeriana, Cinchona officinalis, Cinchona pubescens

Cinchona. This genus of flowering trees and shrubs, belonging to the Rubiaceae family, is native to the tropical Andes forests of western South America. Renowned for its therapeutic bark, the genus was named by Carl Linnaeus in the 18th century, allegedly in honor of the Countess of Chinchón. Its historical and economic importance is inextricably linked to the presence of alkaloids, most famously quinine, within its bark.

Description and taxonomy

Cinchona species are evergreen trees or large shrubs that typically thrive in the cloud forests of the Andes, particularly in regions of Peru, Ecuador, Colombia, and Bolivia. They are characterized by opposite, entire leaves and terminal clusters of fragrant, tubular flowers, often pink or white, which are pollinated by insects such as butterflies and moths. The taxonomic history of the genus is complex, involving early work by Linnaeus and later botanists like Joseph Dalton Hooker of the Royal Botanic Gardens, Kew. Key species of commercial importance include Cinchona calisaya, Cinchona ledgeriana, and Cinchona officinalis. The genus is closely related to other medicinal plants in the Rubiaceae, such as the source of coffee (*Coffea*).

Historical significance

The use of cinchona bark as a febrifuge was known to indigenous peoples, including the Quechua, long before European contact. Its introduction to Europe is famously associated with the Countess of Chinchón, wife of the Viceroy of Peru, in the 17th century, though this story is now considered apocryphal. The bark, often called Jesuit's bark or Peruvian bark, was promoted by members of the Society of Jesus and became a standard treatment for malaria across Europe and its colonies. Its strategic value shaped colonialism, influencing activities of entities like the British East India Company and the Dutch East India Company in the tropics. The quest to control its supply led to expeditions by figures such as Charles Ledger and conflicts over botanical knowledge.

Medicinal uses and quinine

The primary medicinal value of cinchona lies in its bark, which contains over 20 distinct alkaloids. The most significant of these is quinine, a compound first isolated in pure form by French chemists Pierre Joseph Pelletier and Joseph Bienaimé Caventou in 1820. Quinine became the first effective treatment for malaria, a disease caused by Plasmodium parasites transmitted by Anopheles mosquitoes. Its use was pivotal during major historical events, including the construction of the Panama Canal and military campaigns in regions like the Pacific Theater during World War II. Other alkaloids like quinidine are used in cardiology to treat cardiac arrhythmias. The development of synthetic antimalarials like chloroquine by the German pharmaceutical industry later reduced dependence on natural quinine.

Cultivation and production

Initial European efforts to cultivate cinchona outside South America were driven by the British Empire and the Dutch Empire to break the Spanish and Bolivian monopoly. Key figures included Clements Markham, who organized British expeditions to the Andes. The most successful transplantation was achieved by the Dutch in their colony of the Dutch East Indies (now Indonesia), particularly on Java, using seeds of high-yielding Cinchona ledgeriana procured by Charles Ledger. Plantations were also established in India, Sri Lanka, and later in Africa and the Caribbean. The extraction process involves harvesting the bark, drying it, and then chemically isolating the alkaloids, a major industry for companies like the Dutch-owned Kina Bureau.

Conservation and threats

Wild cinchona populations in their native Andes habitat face several conservation challenges. Primary threats include deforestation for agriculture, particularly cattle ranching, and illegal logging. The fragmentation of cloud forests due to human expansion also threatens the genetic diversity of these species. Some species, like Cinchona officinalis, are considered vulnerable. Conservation efforts involve in-situ protection within national parks like Podocarpus National Park in Ecuador and ex-situ preservation in botanical gardens such as the Royal Botanic Gardens, Kew and the Missouri Botanical Garden. Sustainable cultivation programs and the development of synthetic alternatives have reduced pressure on wild stocks, but habitat loss remains a persistent issue.

Category:Rubiaceae Category:Medicinal plants Category:Flora of South America